back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-04 20:37 Tx date 2026-02-27 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
|
Convertible Notes (US$)
16 - Acquisition or disposition under a prospectus exemption
|
+$100,000 vol |
$100,000 | |
| Filed 2026-03-04 20:28 Tx date 2026-02-27 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
|
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
|
+$100,000 vol |
||
| Filed 2026-03-04 15:01 Tx date 2026-02-27 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
|
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
|
+$100,000 vol |
||
| Filed 2026-03-04 15:01 Tx date 2026-02-27 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
|
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
|
+$100,000 vol |
$100,000 | |
| Filed 2026-03-04 15:01 Tx date 2024-12-11 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
|
Convertible Notes
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-01-22 10:44 Tx date 2025-05-21 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
40,000 | |
| Filed 2026-01-22 10:38 Tx date 2024-12-11 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-04 17:55 Tx date 2025-11-03 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$245.00
+100 vol $2.45 each |
25,900 | |
| Filed 2025-11-03 10:39 Tx date 2025-10-31 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,105
+2,900 vol $2.45 each |
25,800 | |
| Filed 2025-10-30 12:21 Tx date 2025-10-29 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,220
+2,000 vol $2.61 each |
22,900 | |
| Filed 2025-10-28 17:31 Tx date 2025-10-27 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,393
+1,300 vol $2.61 each |
20,900 | |
| Filed 2025-10-27 10:49 Tx date 2025-10-24 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,305
+500 vol $2.61 each |
19,600 | |
| Filed 2025-10-23 13:15 Tx date 2025-10-22 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,917
+3,800 vol $2.61 each |
19,100 | |
| Filed 2025-10-23 13:15 Tx date 2025-10-21 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,874
+3,400 vol $2.61 each |
15,300 | |
| Filed 2025-10-21 14:51 Tx date 2025-10-20 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$522.00
+200 vol $2.61 each |
11,900 | |
| Filed 2025-10-21 14:51 Tx date 2025-10-20 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$512.00
+200 vol $2.56 each |
11,700 | |
| Filed 2025-10-21 14:50 Tx date 2025-10-17 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$764.97
+300 vol $2.55 each |
||
| Filed 2025-10-21 14:47 Tx date 2025-10-17 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$764.97
+300 vol $2.55 each |
||
| Filed 2025-10-20 11:15 Tx date 2025-10-16 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$633.00
+300 vol $2.11 each |
9,100 | |
| Filed 2025-10-20 11:15 Tx date 2025-10-16 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$420.00
+200 vol $2.10 each |
8,800 | |
| Filed 2025-10-20 11:14 Tx date 2025-10-16 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,119
+2,900 vol $2.11 each |
8,600 | |
| Filed 2025-10-20 11:05 Tx date 2025-10-17 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,355
+2,100 vol $2.55 each |
11,500 | |
| Filed 2025-10-20 09:01 Tx date 2025-10-17 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$764.97
+300 vol $2.55 each |
6,000 | |
| Filed 2025-10-20 08:59 Tx date 2025-10-16 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$190.00
+100 vol $1.90 each |
5,700 | |
| Filed 2025-10-14 14:28 Tx date 2025-10-10 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,400
+1,500 vol $1.60 each |
5,600 | |
| Filed 2025-10-09 14:37 Tx date 2025-10-08 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,400
+1,000 vol $1.40 each |
4,100 | |
| Filed 2025-10-08 14:19 Tx date 2025-10-07 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$572.00
+400 vol $1.43 each |
3,100 | |
| Filed 2025-10-08 14:19 Tx date 2025-10-07 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$143.00
+100 vol $1.43 each |
2,700 | |
| Filed 2025-10-08 14:18 Tx date 2025-10-07 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$104.00
+100 vol $1.04 each |
2,600 | |
| Filed 2025-10-06 15:15 Tx date 2025-10-03 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,236
+2,500 vol $0.4947 each |
2,500 | |
| Filed 2025-10-06 15:14 Tx date 2024-12-11 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-05-21 16:21 Tx date 2025-04-22 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$5,000
+3,431 vol $1.46 each |
4,774,743 | |
| Filed 2025-05-21 16:20 Tx date 2025-04-22 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
-3,431 vol |
30,876 | |
| Filed 2025-02-06 14:21 Tx date 2025-01-27 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: William Rankin Newlin III Trust Dated 6/21/2016 (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-85,753 vol |
9,529 | |
| Filed 2025-02-06 14:20 Tx date 2025-01-27 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Tucker Newlin Garvey Trust Dated 6/21/2016 (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-128,629 vol |
14,293 | |
| Filed 2025-02-06 14:19 Tx date 2025-01-27 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: TTEES FBO Douglas John Balsley II (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-171,506 vol |
19,057 | |
| Filed 2025-02-06 14:18 Tx date 2025-01-27 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
|
Warrants
37 - Stock split or consolidation
|
-308,763 vol |
34,307 | |
| Filed 2025-02-06 14:17 Tx date 2025-01-27 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-42,941,799 vol |
4,771,312 | |
| Filed 2025-02-06 14:15 Tx date 2025-01-27 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Maverick Leo Newlin Trust Dated 12/5/17 (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-85,753 vol |
9,529 | |
| Filed 2025-02-06 14:14 Tx date 2025-01-27 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Madison Newlin Garvey Trust Dated 6/21/2016 (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-128,629 vol |
14,293 | |
| Filed 2025-02-06 14:13 Tx date 2025-01-27 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Jaspar Rock Newlin Trust Dated 6/21/2016 (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-85,753 vol |
9,529 | |
| Filed 2024-12-18 11:28 Tx date 2024-12-11 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
343,070 | ||
| Filed 2024-12-18 11:27 Tx date 2024-12-11 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: William Rankin Newlin III Trust Dated 6/21/2016 (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
95,282 | ||
| Filed 2024-12-18 11:26 Tx date 2024-12-11 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Tucker Newlin Garvey Trust Dated 6/21/2016 (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
142,922 | ||
| Filed 2024-12-18 11:25 Tx date 2024-12-11 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: TTEES FBO Douglas John Balsley II (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
190,563 | ||
| Filed 2024-12-18 11:25 Tx date 2024-12-11 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
47,713,111 | ||
| Filed 2024-12-18 11:24 Tx date 2024-12-11 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Maverick Leo Newlin Trust Dated 12/5/17 (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
95,282 | ||
| Filed 2024-12-18 11:23 Tx date 2024-12-11 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Madison Newlin Garvey Trust Dated 6/21/2016 (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
142,922 | ||
| Filed 2024-12-18 11:23 Tx date 2024-12-11 |
$SHRX
Sharp Therapeutics Corp. |
Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Jaspar Rock Newlin Trust Dated 6/21/2016 (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
95,282 |